Tentative Approvals - November 2005

Tentative Approvals - December 2005

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 77-345 SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE)   PUREPAC PHARMACEUTICAL COMPANY 12/6/2005 
2 76-748 ROSIGLITAZONE MALEATE TABLETS, 2 MG (BASE), 4 MG (BASE), AND 8 MG (BASE)   DR. REDDY'S LABORATORIES LIMITED 12/7/2005 
3 77-129 RIVASTIGMINE TARTRATE CAPSULES, 1.5 MG (BASE), 3 MG (BASE), 4.5 MG (BASE), AND 6 MG (BASE)   WATSON LABORATORIES, INC. 12/7/2005 
4 77-376 MIRTAZAPINE ORALLY DISINTEGRATING TABLETS, 45 MG   AUROBINDO PHARMA LIMITED 12/8/2005 
5 76-798 PIOGLITAZONE HYDROCHLORIDE TABLETS, 15 MG (BASE), 30 MG (BASE), AND 45 MG (BASE)   WATSON LABORATORIES, INC. 12/13/2005 
6 77-136 TERBINAFINE HYDROCHLORIDE TABLETS, 250 MG (BASE)   GENPHARM INC. 12/13/2005 
7 76-596 MODAFINIL TABLETS, 100 MG AND 200 MG   TEVA PHARMACEUTICALS USA 12/16/2005 
8 77-299 SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE)   PLIVA HRVATSKA D.O.O. 12/21/2005 
9 77-363 RIVASTIGMINE TARTRATE ORAL SOLUTION, 2 MG (BASE)/ML   RANBAXY INC. 12/21/2005 
10 77-774 STAVUDINE FOR ORAL SOLUTION USP, 1 MG/ML   AUROBINDO PHARMA LIMITED 12/21/2005 
11 76-442 SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE)   DR. REDDY'S LABORATORIES LIMITED 12/27/2005 
12 77-221 LAMIVUDINE TABLETS, 150 MG AND 300 MG   WATSON LABORATORIES, INC. 12/27/2005 
13 77-378 CARVEDILOL TABLETS, 3.125 MG   CARACO PHARMACEUTICAL LABORATORIES, LTD. 12/27/2005 
14 77-702 NEVIRAPINE ORAL SUSPENSION, 50 MG/5 ML   AUROBINDO PHARMA LIMITED 12/29/2005 
15 77-335 FINASTERIDE TABLETS USP, 1 MG   WATSON LABORATORIES, INC. 12/29/2005 
16 76-532 SIMVASTATIN TABLETS USP, 5 MG, 10 MG, 20 MG, 40 MG, AND 80 MG   TEVA PHARMACEUTICALS USA 12/30/2005 

Back to Top     Back to Approvals

Date created: January 18, 2006

horizonal rule

Avandia Case Evaluation Form

This form is secure and encrypted. More information about secure forms and your privacy here.

YOUR CONTACT INFORMATION

First Name: *
Last Name: *
E-mail Address: *
Address:
City:
State: *
Zipcode:
Phone: -- xtn

CASE INFORMATION

Why Was Avandia Prescribed?: *
What Dosage, in Milligrams?:
How Frequently Was Avandia Taken?:
Date Patient Began Taking Avandia:

Stopped Taking Avandia:

What Symptoms Were Experienced?: *
Heart Attack
Stroke
Heart Failure

Death
Other
PPH
If "Other", Please Describe:
How Long Was it From the Last Dose to the Problems Appearing?:
    Within 1 Day 2 Days 3 Days
    More Than 3 Days Don't Know
Questions/Comments:

Need An Avandia Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Avandia Case - Submit Your Information Below

Do you need legal assistance with your Avandia case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

YOUR CONTACT INFORMATION

First Name: *
Last Name: *
E-mail Address: *
Address:
City:
State: *
Zipcode:
Phone: -- xtn

CASE INFORMATION

Why Was Avandia Prescribed?: *
What Dosage, in Milligrams?:
How Frequently Was Avandia Taken?:
Date Patient Began Taking Avandia:

Stopped Taking Avandia:

What Symptoms Were Experienced?: *
Heart Attack
Stroke
Heart Failure

Death
Other
PPH
If "Other", Please Describe:
How Long Was it From the Last Dose to the Problems Appearing?:
    Within 1 Day 2 Days 3 Days
    More Than 3 Days Don't Know
Questions/Comments:
This form is secure and encrypted. More information about secure forms and your privacy here.